Open Text Corporation announced its support for the Secure Access For Everyone (SAFE) initiative. SAFE was unveiled by a group of biopharmaceutical companies, in cooperation with regulators and industry associations, to provide an open, global standard for secure and legally enforceable digitally signed e-documents exchanged among biopharmaceutical companies and with their regulators. The SAFE initiative will address the challenge of securely sharing massive, complex regulatory documents produced during research and development, and submitted to regulators to gain approvals on new drugs or medical devices. SAFE will establish a digital identity standard that will help create a common, trusted infrastructure between companies, partners and regulators. The SAFE model will allow pharmaceutical and life sciences organizations to meet the requirements for document authentication, legally binding digital signatures, integrity, uniform liability controls and privacy through the use of existing technology. Open Text will introduce and market a fully compliant Livelink solution for SAFE shortly after the SAFE certification process is in place. www.opentext.com/pharmaceutical/safe.html

Share